APA (7th ed.) Citation

Mayer, M., Berger, A., Leischner, C., Renner, O., Burkard, M., Böcker, A., . . . Venturelli, S. (2022). Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma. Pharmaceuticals (14248247), 15(4), N.PAG. https://doi.org/10.3390/ph15040438

Chicago Style (17th ed.) Citation

Mayer, Mascha, et al. "Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma." Pharmaceuticals (14248247) 15, no. 4 (2022): N.PAG. https://doi.org/10.3390/ph15040438.

MLA (9th ed.) Citation

Mayer, Mascha, et al. "Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma." Pharmaceuticals (14248247), vol. 15, no. 4, 2022, p. N.PAG, https://doi.org/10.3390/ph15040438.